HCV Response in Patients With End Stage Renal Disease Treated With Combination Pegylated Interferon alpha-2a and Ribavirin Article

Industry Collaboration

cited authors

  • Hakim, Wyel; Sheikh, Shehzad; Inayat, Irteza; Caldwell, Cary; Smith, Douglas; Lorber, Marc; Friedman, Amy; Jain, Dhanpat; Bia, Margaret; Formica, Richard; Mehal, Wajahat

Publication Date

  • May 1, 2009

webpage

published in

category

keywords

  • combination therapy
  • end stage renal disease
  • hepatitis C virus
  • pegylated interferon
  • ribavirin

start page

  • 477

end page

  • 481

volume

  • 43

issue

  • 5